Amarin Corp Plc (AMRN)

[JRoon71]

Tseven, I agree. However, the new formulation has some built-in advantages; (1) more effective due to uptake method, (2) theoretically less expensive because they are only using half the API (2 pills vs. 4), (3) less "pill burden" (again, 2 pills vs. 4), and (4) WE COULD ACTUALLY START MARKETING AGAIN.

Yes, if we are unsuccessful in re-capturing the US market, then generics could still sell into it. But I think their impact would be greatly diminished.